The impact of COVID-19 pandemic on patients with ANCA associated vasculitis.
CONCLUSION: The incidence of COVID-19 in patients with AAV appears to be similar to that of the general population. For a patient population that requires active clinical surveillance, there is significant disruption in care as a result of the pandemic. Reduction of immunosuppression may not be indicated, and the risk of relapse likely far outweighs the risk of COVID-19.
PMID: 33034038 [PubMed - as supplied by publisher]
Source: Journal of Nephrology - Category: Urology & Nephrology Authors: Kant S, Morris A, Ravi S, Floyd L, Gapud E, Antichos B, Dhaygude A, Seo P, Geetha D Tags: J Nephrol Source Type: research
More News: Coronavirus | COVID-19 | Health Management | Pandemics | Respiratory Medicine | Rituxan | SARS | Study | Urology & Nephrology | Vasculitis